Fred Hutch Cancer Center prostate cancer researcher and medical oncologist Andrew Hsieh, MD, was recently named a 2024 Harrington Scholar-Innovator.
The two-year, $100,000 award, from the Harrington Discovery Institute (HDI) at University Hospitals in Cleveland, will support Hsieh’s efforts to turn an experimental compound into a drug. He is working to target the elevated RNA translation and protein synthesis processes that fuel many tumors, including advanced prostate cancer.
